SCHEMBL26548751

SCHEMBL26548751

CC(C)Nc1cc(OC(F)(F)F)ccn1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 5/20 0.40
MAPK10 P53779 1/20 0.40
PLK1 P53350 1/20 0.40
HRH4 Q9H3N8 2/20 0.39
CYP1A2 P05177 1/20 0.38
BRAF P15056 6/20 0.38
KDR P35968 5/20 0.38
FDPS P14324 1/20 0.37
ATP1A1 P05023 1/20 0.36
ATP1B1 P05026 1/20 0.36
ATP1A3 P13637 1/20 0.36
ATP1B2 P14415 1/20 0.36
ATP1A2 P50993 1/20 0.36
ATP1B3 P54709 1/20 0.36
FXYD2 P54710 1/20 0.36
ATP1A4 Q13733 1/20 0.36
IGF1R P08069 1/20 0.36
HTR7 P34969 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23763117 0.81 RXRA (0.43) BRAFKDRIGF1R
SCHEMBL26547682 0.81 CYP2C9 (0.43) MAPK14MAPK10HRH4CYP1A2BRAF
SCHEMBL26548519 0.80 CCR1 (0.52) MAPK14MAPK10HRH4KDRFDPS
SCHEMBL25211019 0.78 KDR (0.40) HRH4CYP1A2BRAFKDRIGF1R
SCHEMBL26550280 0.78 FDPS (0.48) MAPK14MAPK10HRH4KDRFDPS
SCHEMBL26548744 0.77 NOS1 (0.44) MAPK14MAPK10HRH4CYP1A2FDPS
SCHEMBL26547350 0.75 HCAR3 (0.45) CYP1A2ATP1A1ATP1B1ATP1A3ATP1B2
SCHEMBL12356693 0.75 HRH4 (0.41) HRH4CYP1A2
SCHEMBL17131648 0.75 IDH2 (0.55) MAPK14MAPK10CYP1A2BRAFKDR
SCHEMBL23213851 0.73 KDR (0.49) BRAFKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023196975-A1 COMPOUNDS THAT INTERACT WITH RAS SUPERFAMILY PROTEINS FOR TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE SHY THERAPEUTICS, LLC (US) 2023-10-12 WO disclosed